Patient Characteristics, Testing and Treatment Patterns, and Outcomes in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multinational, Real-World Study
ConclusionThis real-world multinational data set showed that most patients withEGFRm+ aNSCLC were treated per the country relevant clinical guidelines, with progression as the main reason for early treatment discontinuation. For the included countries, these findings may offer a useful benchmark for decision makers to determine future allocation of healthcare resources for patient s withEGFRm+ aNSCLC.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Adenocarcinoma | Brazil Health | Cancer | Cancer & Oncology | Cough | Drugs & Pharmacology | France Health | Germany Health | Italy Health | Japan Health | Lung Cancer | Non-Small Cell Lung Cancer | Spain Health | Study | Taiwan Health